Davis Todd C bought LGND
March 25, 2024 · Form 4 insider transaction
Davis Todd C bought 3,556 shares of Ligand Pharmaceuticals Incorporated at $66.19 per share, a transaction worth $235.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,556
Price
$66.19
Total value
$235.4K
InsiderDavis Todd C
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 25, 2024
Filing dateMarch 27, 2024
Shares owned after120,160
OwnershipDirect
10b5-1 planNo
AmendedNo